These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 22918631
1. Correlation of SD-OCT features and retinal sensitivity in neovascular age-related macular degeneration. Sulzbacher F, Kiss C, Kaider A, Eisenkoelbl S, Munk M, Roberts P, Sacu S, Schmidt-Erfurth U. Invest Ophthalmol Vis Sci; 2012 Sep 21; 53(10):6448-55. PubMed ID: 22918631 [Abstract] [Full Text] [Related]
2. Correlation of OCT characteristics and retinal sensitivity in neovascular age-related macular degeneration in the course of monthly ranibizumab treatment. Sulzbacher F, Kiss C, Kaider A, Roberts P, Munk M, Kroh ME, Sayegh R, Schmidt-Erfurth U. Invest Ophthalmol Vis Sci; 2013 Feb 01; 54(2):1310-5. PubMed ID: 23349430 [Abstract] [Full Text] [Related]
3. Relationship of retinal morphology and retinal sensitivity in the treatment of neovascular age-related macular degeneration using aflibercept. Sulzbacher F, Roberts P, Munk MR, Kaider A, Kroh ME, Sacu S, Schmidt-Erfurth U, Vienna Eye Study Center. Invest Ophthalmol Vis Sci; 2014 Dec 11; 56(2):1158-67. PubMed ID: 25503456 [Abstract] [Full Text] [Related]
11. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF. Ophthalmology; 2010 Sep 11; 117(9):1775-81. PubMed ID: 20472293 [Abstract] [Full Text] [Related]
12. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study. Silva R, Cachulo ML, Fonseca P, Bernardes R, Nunes S, Vilhena N, Faria de Abreu JR. Ophthalmologica; 2011 Sep 11; 226(3):110-8. PubMed ID: 21822000 [Abstract] [Full Text] [Related]
13. Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy. Golbaz I, Ahlers C, Stock G, Schütze C, Schriefl S, Schlanitz F, Simader C, Prünte C, Schmidt-Erfurth UM. Invest Ophthalmol Vis Sci; 2011 Mar 01; 52(3):1599-605. PubMed ID: 21051733 [Abstract] [Full Text] [Related]